Renée Aguiar-Lucander
Directeur Général chez CALLIDITAS THERAPEUTICS AB
Fortune : 13 M $ au 31/05/2024
Profil
Renée Julie Elisabet Aguiar-Lucander is currently the Chief Executive Officer at Calliditas Therapeutics AB.
She is also the Chairman at Simparel, Inc., Exenta, Inc., and Director at Egalet A and Ral Capital Ltd.
(United Kingdom).
Previously, Ms. Aguiar-Lucander held positions such as Chairman at EnXray Ltd., Director at SpineVision SA, ImpactRx, Inc., Zyla Life Sciences LLC, Pulmagen Therapeutics (Synergy) Ltd., MedCap AB, Newron Pharmaceuticals SpA, SciBase Holding AB, and NsGene A.
She was also an Independent Director at Egalet Ltd.
from 2010 to 2013.
Additionally, she served as a Director at Onyvax Ltd., Lehman Brothers, Inc. (Milan Branch), Sophion Bioscience A, BioSilta Ltd., Danish BioVenture General Partner ApS, Calliditas Therapeutics France SAS, 3i Group Plc, 3i Venture Capital, and Chief Operating Officer & Partner at Omega Fund Management UK LLP.
Ms. Aguiar-Lucander holds an MBA from INSEAD and an undergraduate degree from Stockholm School of Economics.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/02/2024 | 643 000 ( 1,08% ) | 13 M $ | 31/05/2024 |
Postes actifs de Renée Aguiar-Lucander
| Sociétés | Poste | Début |
|---|---|---|
| CALLIDITAS THERAPEUTICS AB | Directeur Général | 18/05/2017 |
Egalet A/S
 Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Directeur/Membre du Conseil | - |
| Ral Capital Ltd. (United Kingdom) | Directeur/Membre du Conseil | - |
Exenta, Inc.
 Exenta, Inc. Packaged SoftwareTechnology Services Exenta, Inc. provides information technology and services. It offers fashion and soft goods ERP software, product lifecycle management, supply chain management, shop floor control (mobile), warehouse management, enterprise resource planning (ERP), electronic data interchange, Mfg and materials planning services. The company is headquartered in New York, NY. | Président | - |
Simparel, Inc.
 Simparel, Inc. Miscellaneous Commercial ServicesCommercial Services Simparel, Inc. provides global supply chain management solutions. It provides apparel manufacturing software solutions. The firm offers enterprise resource planning, product lifecycle management, supply chain management, warehouse management system, mobile wholesale solution, electronic data interchange, manufacturing, material resource planning and financial management solutions. The company was founded in 2007 and is headquartered in New York, NY. | Président | - |
Anciens postes connus de Renée Aguiar-Lucander
| Sociétés | Poste | Fin |
|---|---|---|
| ZYLA LIFE SCIENCES | Directeur/Membre du Conseil | 10/06/2015 |
Egalet Ltd.
 Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Président | 08/05/2012 |
3i Venture Capital
 3i Venture Capital Investment ManagersFinance 3i Venture Capital (3i VC) is the venture capital division of 3i Investments Plc, ultimately owned by 3i Group Plc (LSE: III) in Great Britain. Created in 2001 when 3i aligned their organizational structure along global business lines, 3i VC invests globally in seed- to late-stage technology and healthcare businesses. Based in London, the firm has additional offices in Birmingham, Cambridge, Paris, Boston, San Francisco, Stockholm, Hong Kong, Stuttgart and Munich. | Private Equity Investor | 31/12/2008 |
| Lehman Brothers, Inc. (Milan Branch) | Corporate Officer/Principal | 01/01/2003 |
| ░░░░░░ ░░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | - |
Formation de Renée Aguiar-Lucander
| INSEAD | Masters Business Admin |
| Stockholm School of Economics | Undergraduate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 5 |
|---|---|
| NEWRON PHARMACEUTICALS S.P.A. | Health Technology |
| SCIBASE HOLDING AB (PUBL) | Health Technology |
| 3I GROUP PLC | Finance |
| CALLIDITAS THERAPEUTICS AB | Health Technology |
| MEDCAP AB | Health Technology |
| Entreprise privées | 19 |
|---|---|
Pulmagen Therapeutics (Synergy) Ltd.
 Pulmagen Therapeutics (Synergy) Ltd. Miscellaneous Commercial ServicesCommercial Services Pulmagen Therapeutics (Synergy) Ltd. develops therapeutics for respiratory diseases. It engages in developing various internal proprietary programs in chronic obstructive pulmonary disease, asthma, and cystic fibrosis. The company was founded in August 2000 and is headquartered in Stevenage, the United Kingdom. | Commercial Services |
Zyla Life Sciences LLC
 Zyla Life Sciences LLC Pharmaceuticals: MajorHealth Technology Zyla Life Sciences is a commercial-stage company, which focuses on developing, manufacturing and commercializing innovative treatments for pain. It is focused on bringing non-narcotic products and abuse-discouraging formulations of opioids to patients and healthcare providers. The company plans to continue to grow revenue of its seven commercial products, which includes Sprix nasal spray, Vivlodex, Zorvolex, Tivorbex, Indocin suppositories, Indocin oral suspension and oxaydo tablets, and explore business development opportunities. Zyla Life Sciences was founded in August 2013 and is headquartered in Wayne, PA. | Health Technology |
Onyvax Ltd.
 Onyvax Ltd. Miscellaneous Commercial ServicesCommercial Services Onyvax Ltd. developed cancer remedy therapies. The company was founded in 1995 and was headquartered in Bradford, the United Kingdom. | Commercial Services |
ImpactRx, Inc.
 ImpactRx, Inc. Miscellaneous Commercial ServicesCommercial Services ImpactRx, Inc. was provided health-care sector custom research and promotional consultancy services. The company was founded by Lawrence G. Miller, Terry Overton and Gerald J. Gallivan in 2000 and was headquartered in Horsham, PA. | Commercial Services |
| Lehman Brothers, Inc. (Milan Branch) | Finance |
NsGene A/S
 NsGene A/S Pharmaceuticals: MajorHealth Technology NsGene A/S identifies neurotrophic proteins with therapeutic effects in the nervous system. It is a biotechnology company that focuses primarily on neurodegenerative disorders. The firm provides technologies that target protein therapeutics across the blood-brain-barrier and directly to diseased nerve cells. It develops therapeutic products for multiple indications with high medical needs including Alzheimer’s disease, Parkinson's disease, deafness, neuropathic pain, epilepsy, cortico-basal degeneration, and Huntington’s disease. The company was founded by Lars Ulrik Wahlberg and Teit Eliot Johansen in 1999 and is headquartered in Ballerup, Denmark. | Health Technology |
Sophion Bioscience A/S
 Sophion Bioscience A/S Medical SpecialtiesHealth Technology Sophion Bioscience A/S develops, manufactures and markets instruments and supplies automated patch clamping. It develops throughput patch clamp solutions for functional characterization of living cells. The firm products are used in pharmaceutical and biotech companies around the world. The company was founded in July 2007 and is headquartered in Ballerup, Denmark. | Health Technology |
Egalet Ltd.
Egalet Ltd. Pharmaceuticals: MajorHealth Technology Egalet Ltd. engages in manufacturing of basic pharmaceutical products. It focuses on the commercialization and development of abuse resistant formulations of opioids and other pain care drugs. The company was founded on July 15, 2010 and is headquartered in London, the United Kingdom. | Health Technology |
SpineVision SA
 SpineVision SA Medical SpecialtiesHealth Technology SpineVision SA develops and markets implants for the treatment of spinal disorders. It also designs instrumentation for the spinal treatments. Its products include Flex 2, Lumis, Plus/X-Plus, ULIS, Unithread, Spacevisions, and C3. The firm also offers solutions for spinal pathologies, such as lumbar degenerative disc diseases, deformities, cervical disorders, trauma, and tumors. The company was founded by Gérard Vanacker on July 16, 1999 and is headquartered in Antony, France. | Health Technology |
3i Venture Capital
3i Venture Capital Investment ManagersFinance 3i Venture Capital (3i VC) is the venture capital division of 3i Investments Plc, ultimately owned by 3i Group Plc (LSE: III) in Great Britain. Created in 2001 when 3i aligned their organizational structure along global business lines, 3i VC invests globally in seed- to late-stage technology and healthcare businesses. Based in London, the firm has additional offices in Birmingham, Cambridge, Paris, Boston, San Francisco, Stockholm, Hong Kong, Stuttgart and Munich. | Finance |
Danish BioVenture General Partner ApS
 Danish BioVenture General Partner ApS Financial ConglomeratesFinance Danish BioVenture General Partner ApS operates as a general partner and renders investment advice to K/S Danish BioVenture. It manages the administration and acts as a representative of Danish BioVenture in external commercial relations. The company was founded on June 26, 2009 and is headquartered in Copenhagen, Denmark. | Finance |
Egalet A/S
Egalet A/S Pharmaceuticals: MajorHealth Technology Egalet A/S operates as a specialty pharmaceuticals company. It develops opioid formulations for pain management based on abuse deterrent prolonged release erosion matrix technology in Denmark. The company develops prolonged and delayed release therapeutics for chronic pain management, including Parvulet, a delivery platform for facilitating dispensing of oral doses to pediatric and geriatric patient segments; and Egalet morphine. The company was founded by Jan Quistgaard in 1995 and is headquartered in Vaerloese, Denmark. | Health Technology |
BioSilta Ltd.
 BioSilta Ltd. BiotechnologyHealth Technology BioSilta Ltd. provides cell culture technology for laboratory researchers. It develops different uses of enzyme and biocatalytic activity to advance cell culture technology across a range of product formats and bacteria. The company was founded by Peter Neubauer in 2007 and is headquartered in Oulu, Finland. | Health Technology |
Simparel, Inc.
Simparel, Inc. Miscellaneous Commercial ServicesCommercial Services Simparel, Inc. provides global supply chain management solutions. It provides apparel manufacturing software solutions. The firm offers enterprise resource planning, product lifecycle management, supply chain management, warehouse management system, mobile wholesale solution, electronic data interchange, manufacturing, material resource planning and financial management solutions. The company was founded in 2007 and is headquartered in New York, NY. | Commercial Services |
EnXray Ltd.
 EnXray Ltd. Information Technology ServicesTechnology Services EnXray Ltd. operates as a medical technology company. Its technology includes low energy x-rays, radiation sterilization and lexr benefits. The company was founded by Edward cappabianca in 2012 and is headquartered in Liverpool, the United Kingdom. | Technology Services |
| Omega Fund Management UK LLP | |
Exenta, Inc.
Exenta, Inc. Packaged SoftwareTechnology Services Exenta, Inc. provides information technology and services. It offers fashion and soft goods ERP software, product lifecycle management, supply chain management, shop floor control (mobile), warehouse management, enterprise resource planning (ERP), electronic data interchange, Mfg and materials planning services. The company is headquartered in New York, NY. | Technology Services |
| Ral Capital Ltd. (United Kingdom) | |
Calliditas Therapeutics France SAS
 Calliditas Therapeutics France SAS Pharmaceuticals: MajorHealth Technology Calliditas Therapeutics France SAS is a biopharmaceutical company, which engages in the NOX therapies. Its therapeutic approach is based on a selective inhibition of NOX enzymes that amplify multiple disease processes, such as fibrosis, inflammation, pain processing, cancer development, and eurodegeneration. The firm’s platform enables the identification of orally available small molecules that selectively inhibit specific NOX enzymes. The company was founded in 2006 and is headquartered in Saint-Julien-en-Genevois, France. | Health Technology |
